Sumitomo Mitsui Trust Group Inc. decreased its stake in shares of Universal Health Services, Inc. (NYSE:UHS – Free Report) by 2.5% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 158,267 shares of the health services provider’s stock after selling 4,071 shares during the quarter. Sumitomo Mitsui Trust Group Inc. owned about 0.24% of Universal Health Services worth $28,396,000 as of its most recent filing with the Securities & Exchange Commission.
Several other hedge funds also recently modified their holdings of UHS. State Street Corp grew its holdings in Universal Health Services by 0.6% in the third quarter. State Street Corp now owns 2,724,075 shares of the health services provider’s stock worth $623,840,000 after purchasing an additional 17,527 shares during the period. Geode Capital Management LLC boosted its position in shares of Universal Health Services by 4.0% during the 3rd quarter. Geode Capital Management LLC now owns 1,661,530 shares of the health services provider’s stock worth $379,403,000 after purchasing an additional 63,754 shares in the last quarter. JPMorgan Chase & Co. grew its stake in shares of Universal Health Services by 0.9% in the 3rd quarter. JPMorgan Chase & Co. now owns 1,197,537 shares of the health services provider’s stock valued at $274,248,000 after buying an additional 10,578 shares during the period. Charles Schwab Investment Management Inc. increased its position in Universal Health Services by 1.9% in the 3rd quarter. Charles Schwab Investment Management Inc. now owns 603,705 shares of the health services provider’s stock valued at $138,254,000 after buying an additional 11,353 shares in the last quarter. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC raised its stake in Universal Health Services by 13.5% during the 3rd quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 346,969 shares of the health services provider’s stock worth $79,459,000 after buying an additional 41,218 shares during the period. Institutional investors own 86.05% of the company’s stock.
Universal Health Services Stock Performance
Shares of Universal Health Services stock opened at $185.93 on Wednesday. The firm has a market capitalization of $12.27 billion, a P/E ratio of 12.36, a price-to-earnings-growth ratio of 0.54 and a beta of 1.30. The company has a current ratio of 1.39, a quick ratio of 1.28 and a debt-to-equity ratio of 0.69. The business’s fifty day simple moving average is $185.93 and its 200 day simple moving average is $207.89. Universal Health Services, Inc. has a 12 month low of $152.68 and a 12 month high of $243.25.
Universal Health Services Announces Dividend
Insider Activity
In other news, Director Maria Ruderman Singer sold 1,614 shares of the business’s stock in a transaction that occurred on Wednesday, December 11th. The shares were sold at an average price of $191.15, for a total value of $308,516.10. Following the sale, the director now owns 5,879 shares of the company’s stock, valued at $1,123,770.85. The trade was a 21.54 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Insiders own 16.10% of the company’s stock.
Analysts Set New Price Targets
Several research firms have recently commented on UHS. Royal Bank of Canada decreased their price objective on Universal Health Services from $222.00 to $211.00 and set a “sector perform” rating for the company in a report on Monday, October 28th. TD Cowen lowered their price objective on shares of Universal Health Services from $275.00 to $251.00 and set a “buy” rating on the stock in a report on Tuesday, November 26th. Cantor Fitzgerald raised shares of Universal Health Services from a “neutral” rating to an “overweight” rating in a research note on Monday, February 3rd. StockNews.com downgraded shares of Universal Health Services from a “strong-buy” rating to a “buy” rating in a research report on Saturday, November 9th. Finally, Barclays raised their price target on shares of Universal Health Services from $256.00 to $271.00 and gave the company an “overweight” rating in a research report on Friday, October 25th. Six equities research analysts have rated the stock with a hold rating, ten have assigned a buy rating and one has given a strong buy rating to the stock. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $226.14.
Read Our Latest Stock Analysis on Universal Health Services
Universal Health Services Company Profile
Universal Health Services, Inc, through its subsidiaries, owns and operates acute care hospitals, and outpatient and behavioral health care facilities. It operates through Acute Care Hospital Services and Behavioral Health Care Services segments. The company's hospitals offer general and specialty surgery, internal medicine, obstetrics, emergency room care, radiology, oncology, diagnostic and coronary care, pediatric services, pharmacy services, and/or behavioral health services.
Further Reading
- Five stocks we like better than Universal Health Services
- How to invest in marijuana stocks in 7 stepsÂ
- META Stock: Insider Selling Ramps Up—What It Means for Investors
- What is a Dividend Harvesting Strategy and How Can Investors Profit from it?
- 3 Chip Stocks Still Trading 50% Below Their 52-Week Highs
- What is Forex and How Does it Work?
- U.S. Steel: Will Trump-Backed Nippon Investment Drive Upside?
Want to see what other hedge funds are holding UHS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Universal Health Services, Inc. (NYSE:UHS – Free Report).
Receive News & Ratings for Universal Health Services Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Universal Health Services and related companies with MarketBeat.com's FREE daily email newsletter.